116 related articles for article (PubMed ID: 17122790)
1. Late stent thrombosis in drug-eluting stents: return of the 'VB syndrome'.
Serruys PW; Kukreja N
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):637. PubMed ID: 17122790
[No Abstract] [Full Text] [Related]
2. Drug-eluting stent thrombosis: it's never too late.
Kandzari DE
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):638-9. PubMed ID: 17122791
[No Abstract] [Full Text] [Related]
3. Stent thrombosis with drug-eluting stents: a re-examination of the evidence.
Kedia G; Lee MS
Catheter Cardiovasc Interv; 2007 May; 69(6):782-9. PubMed ID: 17394249
[TBL] [Abstract][Full Text] [Related]
4. Do the benefits outweigh the risks with drug-eluting stents?
Kløw NE
Scand Cardiovasc J; 2007 Jan; 41(1):8-9. PubMed ID: 17365970
[No Abstract] [Full Text] [Related]
5. Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet...
Nakazawa G; Ladich E; Virmani R
Clin Pharmacol Ther; 2009 Aug; 86(2):127-30. PubMed ID: 19621005
[No Abstract] [Full Text] [Related]
6. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
7. Assessing the landscape of stent thrombosis: the drug-eluting versus bare-metal stent controversy.
Rizik DG; Klassen KJ
Am J Cardiol; 2008 Nov; 102(9 Suppl):4J-11J. PubMed ID: 18928786
[TBL] [Abstract][Full Text] [Related]
8. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years.
Ellis SG; Colombo A; Grube E; Popma J; Koglin J; Dawkins KD; Stone GW
J Am Coll Cardiol; 2007 Mar; 49(10):1043-51. PubMed ID: 17349883
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
Schömig A; Dibra A; Windecker S; Mehilli J; Suárez de Lezo J; Kaiser C; Park SJ; Goy JJ; Lee JH; Di Lorenzo E; Wu J; Jüni P; Pfisterer ME; Meier B; Kastrati A
J Am Coll Cardiol; 2007 Oct; 50(14):1373-80. PubMed ID: 17903638
[TBL] [Abstract][Full Text] [Related]
10. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.
Buonamici P; Marcucci R; Migliorini A; Gensini GF; Santini A; Paniccia R; Moschi G; Gori AM; Abbate R; Antoniucci D
J Am Coll Cardiol; 2007 Jun; 49(24):2312-7. PubMed ID: 17572245
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
Piscione F; Piccolo R; Cassese S; Galasso G; Chiariello M
Catheter Cardiovasc Interv; 2009 Aug; 74(2):323-32. PubMed ID: 19360858
[TBL] [Abstract][Full Text] [Related]
12. [Late stent thrombosis with drug eluting stents: disturbing signals on the radar].
Hansen PR
Ugeskr Laeger; 2007 Apr; 169(17):1561-3. PubMed ID: 17484825
[TBL] [Abstract][Full Text] [Related]
13. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
14. Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries.
Artang R; Dieter RS
Am J Cardiol; 2007 Apr; 99(8):1039-43. PubMed ID: 17437724
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.
Pasceri V; Patti G; Speciale G; Pristipino C; Richichi G; Di Sciascio G
Am Heart J; 2007 May; 153(5):749-54. PubMed ID: 17452148
[TBL] [Abstract][Full Text] [Related]
17. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
Zhao FH; Chen YD; Jin ZN; Lu SZ
Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
[TBL] [Abstract][Full Text] [Related]
18. Safety of drug-eluting stents.
Windecker S; Jüni P
Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):316-28. PubMed ID: 18414453
[TBL] [Abstract][Full Text] [Related]
19. Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task Force.
Hodgson JM; Stone GW; Lincoff AM; Klein L; Walpole H; Bottner R; Weiner BH; Leon MB; Feldman T; Babb J; Dehmer GJ;
Catheter Cardiovasc Interv; 2007 Feb; 69(3):327-33. PubMed ID: 17219373
[No Abstract] [Full Text] [Related]
20. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
